Patient-specific dosimetry of ^sup 99m^Tc-HYNIC-Tyr^sup 3^-Octreotide in children
Patient-specific dosimetry of ^sup 99m^Tc-HYNIC-Tyr^sup 3^-Octreotide in children
About this item
Full title
Author / Creator
Publisher
Heidelberg: Springer Nature B.V
Journal title
Language
English
Formats
Publication information
Publisher
Heidelberg: Springer Nature B.V
Subjects
More information
Scope and Contents
Contents
Technetium-99m-hydrazinonicotinamide-Tyr3-octreotide (99mTc-HYNIC-TOC) is recognized as a promising radiopharmaceutical for diagnosing neuroendocrine tumors (NETs). However, 99mTc-HYNIC-TOC dosimetry has been investigated only for adults. As pediatric radionuclide therapies become increasingly common, similar dosimetric studies for children are urg...
Alternative Titles
Full title
Patient-specific dosimetry of ^sup 99m^Tc-HYNIC-Tyr^sup 3^-Octreotide in children
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1957713192
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1957713192
Other Identifiers
E-ISSN
2197-7364
DOI
10.1186/s40658-017-0191-6
